Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks
While semaglutide is effective for managing diabetes and aiding weight loss, it can cause skin reactions in some users
A new study suggests a potential connection between semaglutide use and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION), a blinding eye disease
Not intended for general public promotion
Several strategies help minimize it
Are both medications available through PlexusDx
.png)
US$ 21.74
US$ 29.65
US$ 21.69
US$ 26.85
